Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by Longies123on Nov 20, 2019 9:15pm
215 Views
Post# 30376414

RE:RE:RyplazimTM (plasminogen)

RE:RE:RyplazimTM (plasminogen)You are probably right that its all ready for real action now ...... 

But for people like me who have invested 300k in this company over 15 years we will never make our money back, The initial investors really got fooled by these guys really not right.
Hopefully the original investors the ones who belived in them and helped them financially for many years get something in return,
And not a slap in the face and a kick in the butt like we got in April  
<< Previous
Bullboard Posts
Next >>